Today: 21 March 2026
VeriSilicon (688521.SH) A-shares climb as China posts 5% 2025 GDP and PBOC easing kicks in
19 January 2026
1 min read

VeriSilicon (688521.SH) A-shares climb as China posts 5% 2025 GDP and PBOC easing kicks in

Shanghai, Jan 19, 2026, 10:09 CST — Regular session.

VeriSilicon Microelectronics (Shanghai) Co., Ltd.’s Class A shares were up 3.0% at 183.4 yuan by 9:57 a.m. in Shanghai, after a flat open, with the Shanghai Composite little changed. Turnover was about 1.2 billion yuan, and the stock traded in a 175.69–184.97 yuan range, according to AASTOCKS data. AAStocks

For investors, the timing matters. VeriSilicon sits in the middle of China’s push to build more chips at home, and it tends to trade on shifts in policy and risk appetite as much as on its own order book. StockAnalysis

Monday delivered both. Growth numbers landed mid-morning, and a central bank move aimed at steering cheaper funding into “strategic areas” took effect the same day — the sort of backdrop that can move high-beta chip names quickly.

China’s gross domestic product grew 5% year on year in 2025, meeting the government’s annual target of around 5%, state media Xinhua reported after official data was released on Monday. Xinhua News

The People’s Bank of China said it would cut interest rates on “structural” policy tools by 25 basis points — a basis point is 0.01 percentage point — effective Jan. 19, and expand its tech-innovation re-lending programme by 400 billion yuan to 1.2 trillion yuan. “It probably won’t take very long to see a full policy rate cut,” said Tianchen Xu, senior economist at the Economist Intelligence Unit. Reuters

Chip headlines elsewhere in Asia also stayed supportive. U.S. memory maker Micron said it would buy Powerchip Semiconductor Manufacturing’s P5 fabrication plant in Taiwan for $1.8 billion in cash, lifting Powerchip shares by nearly 10% on Monday, Reuters reported. Reuters

VeriSilicon has also been in deal mode at home. Earlier this month, it disclosed the completion of the acquisition of DPoint Semiconductor (逐点半导体) with co-investors and separately flagged a change in holdings by a shareholder owning more than 5%, filings showed. vip.stock.finance.sina.com.cn

But the trade cuts both ways. A new U.S. proclamation imposing a 25% tariff on certain advanced computing chips adds another layer of uncertainty to global chip demand and supply chains, even as China tries to ring-fence its own ecosystem. Reuters

Next up, investors will watch the PBOC’s monthly loan prime rate fixing — a benchmark that influences corporate and household borrowing costs — due on Jan. 20, after the central bank shifted the release time to 9:15 a.m. local time. Investing.com

Stock Market Today

  • QBIO Q BioMed Surges to $0.00010 on PNK Exchange, Driven by Speculative Biotech Momentum
    March 20, 2026, 8:26 PM EDT. QBIO stock rose sharply to USD 0.00010 on March 21, 2026, on the PNK exchange, reflecting a near 9,900% intraday increase with 5,700 shares traded, above its average volume. The microcap biotech's market cap stands at USD 14,509. Price gains linked to low liquidity and speculative flows underscore volatility risks. Q BioMed, active in biomedical acceleration with drug candidates for cancer, glaucoma, and autism, shows extreme valuation metrics and tight liquidity. Technicals indicate a strong short-term trend but neutral momentum. Meyka AI scores the stock a 'B' with a hold suggestion, balancing financial, sector, and forecast data. Investors should weigh volatile trading, execution risks, and potential pipeline developments influencing the stock's outlook.
China Resources Microelectronics stock tumbles in Shanghai after VP role change filing
Previous Story

China Resources Microelectronics stock tumbles in Shanghai after VP role change filing

JCET stock rises again in Shanghai as “advanced packaging” trade draws fresh bids
Next Story

JCET stock rises again in Shanghai as “advanced packaging” trade draws fresh bids

Go toTop